Sara Zborovski practises regulatory and commercial law for companies regulated by Health Canada. Ms. Zborovski assists clients in navigating the regulatory landscape implemented by the Food and Drugs Act, the Cannabis Act and other legislation and associated regulations overseen by Health Canada and the intersection of these with commercial and intellectual property laws. Ms. Zborovski counsels pharmaceutical, cannabis, food and beverage, natural health product, medical device, cosmetic and tobacco companies on market access, authorizations and licensing, product safety and advertising/marketing these products in Canada.
Ms. Zborovski assists with product licence strategies, market access strategies (including assistance with the Common Drug Review and provincial and private formulary listings) and establishment licensing and GMP/GPP programs. On the compliance side, Ms. Zborovski assists clients in developing SOPs and compliance policies, ensuring compliant packaging and labelling (including label reviews), and provides strategic advice on advertising and marketing programs (including assistance with pre-clearance agencies and representing companies in disputes before the Pharmaceutical Advertising Advisory Board and Advertising Standards Canada). She also advises clients on federal and provincial privacy laws, particularly as these relate to healthcare, and federal and provincial access to information and freedom of information matters.
Ms. Zborovski also works with clients in all industries on matters relating to product safety, including crisis management, advocacy before the inspectorate, and product recalls.
Ms. Zborovski has particular experience with the pharmaceutical, cannabis, and food and beverage industries. She has developed a deep understanding of the regulatory and business realities within which these industries operate through her involvement with industry trade associations, thought leadership, and regular communication with various branches of Health Canada.
LL.B., University of Toronto, 2000
B.A., McGill University, 1996
- New York State Bar 2001
- Ontario 2002
Rankings and recognitions
- Canadian Legal Lexpert Directory, (2017): recommended in Biotechnology
- LMG Life Sciences, Life Science Star (Regulatory), 2013-2015
- "Eye on Enforcement: Canada's Green Rush - Getting Ready for the Legalization of Adult-Use Cannabis" (co-author), FDLI Update, August-September 2018.
- "Pricing & Reimbursement - Canada Chapter 2018" (co-author), Global Legal Insights.
- "The International Comparative Legal Guide to: Pharmaceutical Advertising - Canada Chapter 2018" (co-author).
- "Top 10 Updates on Canadian Market Access, Exclusivity, and Pricing Issues" (co-author), FDLI Update, March-April 2018.
- "Pricing & Reimbursement - Canada Chapter 2017" (co-author), Global Legal Insights.
- "The International Comparative Legal Guide to: Pharmaceutical Advertising - Canada Chapter 2017" (co-author).
- Canada Industry Overvew, MJBizCon International, August 2018
- “Compliance in the Digital Era," CBI Pharmaceutical Compliance Congress, June 2018
- "Safe Foods for Canadians and other Health Canada Initiatives - What's New," Canadian Institute of Food Science and Technology Annual Conference, May 2018
- "Federal Regulation of Cannabis," The Canadian Institute Canadian Business Conference, February 2018
- "Constructing Ethical Interactions with Stakeholders," CBI Pharmaceutical Compliance Congress, June 2017
- "Advertising Food, Drugs & Health Products," Advertising & Marketing Law Conference, The Canadian Institute, January 2017
Memberships and activities
- Food and Drug Law Institute's Global Committee, member-at-large
- Instructor, Institute for Food Laws and Regulations Online Course, Michigan State University
- A chair of the University Tribunal, University of Toronto
- Cross-Border Health Dialogue Foundation, Board member (secretary)
- Director, Food Law and Regulatory, Board of the Canadian Institute of Food Science and Technology (national)
Our Life sciences and healthcare team hosted on Wednesday, May 16, 2018 a morning session where industry experts and our lawyers presented a series of sessions on how regulatory changes, disruptive technology and innovation are impacting the life sciences and healthcare sectors..
Wednesday, May 16, 2018
On October 9, U.S. Customs and Border Protection (the CBP) released a Statement on Canada's Legalization of Marijuana and Crossing the Border..
October 12, 2018
Further to our last update, the Ontario government has now introduced legislation providing some additional information about Ontario’s bricks-and-mortar retail of adult-use cannabis..
October 01, 2018
Norton Rose Fulbright is pleased to announce that Sara Zborovski has joined the Toronto office as a partner. She joins the firm from DLA Piper where she was also a partner..
May 10, 2016